Skip to Menu Skip to Search Contact Us Global Websites & Languages Skip to Content

SGS announces that its Life Science division has selected Phase Forward as a preferred partner. As part of the collaboration, SGS will use Phase Forward’s InFormTM electronic data capture (EDC) product to support the data collection, management and analysis for clinical trials.

The selection of the InForm as SGS’ preferred EDC system marks an expansion of SGS Life Science Services’ relationship with Phase Forward. SGS currently uses Phase Forward’s Clintrial™, a comprehensive clinical data management and analysis system that integrates both electronically captured and paper-based study data, as well as Phase Forward’s ClintraceTM software, a highly scalable, adverse event tracking and reporting system. The InForm solution supports thousands of trial sites with near real-time data, providing end-to-end clinical development capabilities designed to improve trial safety, efficiency and cost-effectiveness. SGS Life Science Services has extensive experience with the InForm software through externally hosted customers, however this agreement allows SGS to offer the EDC system as an integral part of the SGS solution set.

Phase Forward is a leading provider of integrated data management solutions for clinical trials and drug safety. The company offers proven solutions for electronic data capture (InForm™), clinical data management (Clintrial™), clinical trials signal detection (CTSD™), strategic pharmacovigilance (WebVDME™ and Signal Management), adverse event reporting (Clintrace™) and applied data standards (WebSDM™). In addition, the company provides services in the areas of application implementation, hosting and validation, data integration, business process optimization, safety data management and industry standards. Phase Forward’s products and services have been utilized in over 10,000 clinical trials involving more than 1,000,000 clinical trial study participants at over 260 organizations and regulatory agencies worldwide.

Additional information about Phase Forward is available at www.phaseforward.com SGS Life Science Services, a Business unit of  the SGS Group, has 30 years of experience as a global Contract Research Organization (CRO) providing a large range of services from preclinical activities to Phase I through IV trials, bio-analytical and QC testing. With more than 1,300 employees in LSS and 2,000 trials performed, SGS Life Science Services serves the pharmaceutical, biotechnology and medical device industries.

SGS Life Science Services Biometrics group is one of the largest EU Data Management CROs, processing over one million CRF pages each year and offering comprehensive expertise, including in-depth experience in CDISC, and extensive high throughput capabilities.

Additional information about SGS is available at www.sgs.com/clinicalresearch

For further information, please contact:

Florent Hédiard
SGS Life Science Marketing

SGS
202 rue de la Croix Nivert
75015 Paris –France
Tel : 33 1 53 78 18 74
Fax: 33 1 45 54 28 64
Website: www.sgs.com/clinicalresearch

About SGS

The SGS Group is the global leader and innovator in inspection, verification, testing and certification services. Founded in 1878, SGS is recognized as the global benchmark in quality and integrity. With more than 48,000 employees, SGS operates a network of over 1,000 offices and laboratories around the world.